Skip to main content
. 2019 Jan 8;21(2):230–238. doi: 10.1016/j.neo.2018.12.003

Table 1.

Summary of Animal Treatment

Treatment Group Number of Tsc2+/− Mice Number of Males Number of Females Treatment Start Age (Months) Treatment End Age (Months) Dosage Number of Animals Killed Due to Loss of Body Weight Within the First Month of Treatment
Vehicle 17 8 9 12 14 10 μl/g 0
3-BrPA 19 9 10 12 14 3 mg/kg 3
CB-839 20 9 11 12 14 200 mg/kg 0
Rapamycin 20 8 12 12 14 4 mg/kg 0
3-BrPA+rapamycin 18 8 10 12 14 3 mg/kg+ 4 mg/kg 3
CB-839+rapamycin 20 8 12 12 14 200 mg/kg+ 4 mg/kg 0
3-BrPA+CB-839 18 8 10 12 14 3 mg/kg+ 200 mg/kg 4

Tsc2+/− mice were treated twice daily with vehicle or CB-839 via gavage and five times a week with 3-BrPA or rapamycin via intraperitoneal injection.

These mice were killed due to significant loss of body weight within the first month of treatment.